Rosiglitazone and Metformin: Outcomes Trial in Nondiabetic Patients With Stable Coronary Syndromes (Romance) Pilot Study

NCT00343395 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

200

Enrollment

OTHER

Sponsor class

Stopped FDA concerns regarding Avandamet

Conditions

Coronary Artery Disease

Interventions

DRUG: AVANDAMET

Sponsor

Intermountain Health Care, Inc.

Collaborators

[object Object]